LBCL: CAR T Benefits Both Young and Old

Older adults with relapsed/refractory large B-cell lymphoma treated with CD19-directed CAR T-cell therapy have similar survival outcomes to younger patients.
MDedge News

source https://www.medscape.com/s/viewarticle/lbcl-car-t-benefits-both-young-and-old-2024a1000dwo?src=rss

Comments

Popular posts from this blog

New AAFP practice guideline sets blood pressure targets for adults with hypertension

RA and RA-ILD Linked to Higher Lung Cancer Risk

A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?